Human umbilical cord-derived mesenchymal stem cell therapy (Shanghai Life Medical Science & Technology)

N/A

Report date: 2025/06/11 11:06:50

Base Information

Drug NameHuman umbilical cord-derived mesenchymal stem cell therapy (Shanghai Life Medical Science & Technology)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Umbilical cord stem cell therapyCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsLung Diseases, Interstitial
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShanghai Life Science & Technology
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Life Science & Technology
Inactive CompaniesN/A
Active IndicationsLung Diseases, Interstitial
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A